NEHI is conducting a project to examine the earliest steps in the Alzheimer's disease patient journey, from screening and assessment for Mild Cognitive Impairment (MCI) and dementia to follow-up steps that may trigger referral to other services for diagnosis of Alzheimer's disease or other neurological disorders.
Join us in person or virtually on May 23 for a roundtable discussion that will provide an opportunity for providers, patients, policymakers, diagnostics developers, pharmaceutical companies, and other stakeholders to discuss pragmatic actions that can be taken to encourage earlier patient screening and assessment, including recommendations for change in policy and practice that will enable adoption of innovative tests and tools for screening, patient assessment, and diagnosis.
Location: In-person at the Kaiser Permanente Center for Total Health, Washington D.C., and virtually via MS Teams (link to be provided closer to the event)
Panel #1: Oncoming Innovations for Screening and Assessment of Mild Cognitive Impairment and Dementia (Moderator: Tom Hubbard, Senior Vice President of Policy Research, NEHI)
Confirmed Panelists Include:
Deborah E. Barnes, PhD, MPH, Professor, Departments of Psychiatry and Behavioral Sciences and Epidemiology & Biostatistics, UCSF Weill Institute for Neurosciences and Osher Center for Integrative Health, University of California, San Francisco
David Bates, PhD, CEO & Co-Founder, Linus Health
James Hendrix, PhD, Executive Director for US Medical Affairs, Eli Lilly & Company
Todd Levine, MD, Chief Medical Officer & Co-Founder, CND Life Sciences; Clinical Neurologist
Josh Soldo, Chief Scientific Officer & Co-Founder, Veravas, Inc.
Panel #2: Implications for Clinical Practice and Health Care Policy of Oncoming Innovations in MCI and Dementia Screening and Assessment (Moderator: Tom Hubbard, Senior Vice President of Policy Research, NEHI)
Confirmed Panelists Include:
Amanda Bartelme, Executive Director, Policy, Eisai, Inc.
Angela Hsu, MD, Physician Director of Memory Care Services, Mid-Atlantic Permanente Medical Group
Ian Kremer, JD, Executive Director, LEAD (Leaders Engaged on Alzheimer’s Disease) Coalition
Scott Sarran, MD, Chief Medical Officer, Harmonic Health
Karen Tracy, Vice President of Strategic Alliances & Integrated Communications, Gerontological Society of America
Julie Wood, MD, MPH, FAAFP, Senior Vice President of Science and Clinical Strategy, American Academy of Family Physicians; Family Physician